TB-500 (Thymosin Beta-4) (10mg)

Pharmaceutical-grade research peptide, lyophilized for stability. Each batch is independently tested and COA-verified with ≥99% purity by HPLC analysis. Intended exclusively for research purposes.

TB-500 is linked in research contexts to thymosin beta-4-related processes including cell migration, angiogenesis, wound healing and tissue repair. The literature focuses primarily on preclinical models for skin, muscle, cardiac and connective tissue repair. Studies investigate re-epithelialisation, anti-inflammatory responses and regeneration of damaged tissue. This makes TB-500 primarily a subject of investigation within regenerative biology.

For laboratory research use only. This information describes areas of scientific investigation and does not constitute medical advice, dosing guidance or therapeutic claims.